A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101

NCT05667129 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: XEN-101
DRUG: Placebo

Sponsor

Xeno Biosciences